Fri, October 4, 2024
AUS Edition NZ Edition UK Edition CA Edition USA Edition FRA Edition GER Edition ESP Edition ITA Edition NLD Edition
PRT Edition SWE Edition GRC Edition IND Edition POL Edition BRA Edition ZAF Edition RUS Edition CHN Edition UAE Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. HLS
Healthcare
Facebook Twitter Linkedin

HLS Therapeutics Inc (TSX:HLS)

3.71 CAD

0.000 0.000%
Last Updated at: 2024-10-03T19:39:00Z

HLS Therapeutics Inc

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; Vascepa, an icosapent ethyl capsules for cardiovascular disease; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the United States marketing rights of Absorica, a commercial stage dermatology product; Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

10 Carlson Court, Etobicoke, ON, Canada, M9W 6L2

647 495 9000

https://www.hlstherapeutics.com

Employees: 99

Key Executives

Sr. No. Name Title Year Born
1. Mr. Gregory David Gubitz B.A., L.L.B., LL.B Co-Founder & Chairman 1957
2. Mr. Gilbert Godin Co-Founder, CEO & Director 1959
3. Mr. Tim Hendrickson M.B.A. Chief Financial Officer 1972
4. Mr. Sanjiv Sharma Chief Commercial Officer 1956
5. Mr. Ryan C. Lennox B.A., J.D. Sr. VP of Legal, HR & Compliance and Corp. Sec. 1981
6. David Spence Corp. Controller 1968

Peers

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
BHC

Bausch Health Companies Inc

 +0.190 1.726% 11 0.000 2.100 0.468 18.742 3.889 18.184
TLRY

Tilray Inc

 +0.030 1.316% 2.26 0.000 1000.000 2.908 0.447 3.427 -1.946
CRON

Cronos Group Inc

 +0.145 5.000% 2.9 0.000 0.000 11.242 0.674 0.068 1.018
TSND

TerrAscend Corp.

 +0.010 0.581% 1.73 0.000 0.000 0.000 0.000 0.000 0.000

Income Statement

(Currency in CAD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Income Before Tax -23.722M -11.808M -16.299M -20.463M -28.803M
Minority Interest - - - - -
Net Income -23.598M -13.117M -15.331M -19.552M -24.806M
Selling General Administrative 17.735M 17.397M 18.485M 18.09M 14.463M
Gross Profit 56.486M 56.037M 52.484M 52.228M 58.82M
Reconciled Depreciation 34.402M 30.264M 33.186M 32.51M 32.395M
Ebit -13.44M -6.24M -11.256M -4.043M -10.956M
Ebitda 20.962M 24.024M 21.93M 28.467M 21.439M
Depreciation And Amortization 34.402M 30.264M 33.186M 32.51M 32.395M
Operating Income -13.44M -6.24M -11.256M -4.043M -10.956M
Other Operating Expenses 74.964M 66.293M 68.196M 58.788M 53.776M
Interest Expense 7.317M 6.956M 6.307M 7.699M 17.11M
Tax Provision -0.124M 1.309M -0.968M -0.911M -3.997M
Interest Income 0.057M 0.044M 0.322M 0.585M 0.356M
Net Interest Income -7.26M -6.912M -5.985M -7.114M -35.705M
Income Tax Expense -0.124M 1.309M -0.968M -0.911M -3.997M
Total Revenue 61.467M 60.009M 56.109M 54.16M 61.415M
Total Operating Expenses 69.983M 62.321M 64.571M 56.856M 51.181M
Cost Of Revenue 4.981M 3.972M 3.625M 1.932M 2.595M
Total Other Income Expense Net -10.282M -5.568M -5.043M -16.42M -17.847M
Net Income From Continuing Ops -23.598M -13.117M -15.331M -19.552M -24.806M
Net Income Applicable To Common Shares -23.598M -13.117M -15.331M -19.552M -24.806M

Balance Sheet

(Currency in CAD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Total Assets 241.652M 275.905M 303.906M 319.671M 306.425M
Intangible Assets 195.018M 229.181M 253.404M 252.05M 271.153M
Other Current Assets 3.555M 4.52M 2.172M 2.109M -2.073M
Total Liab 116.334M 115.169M 134.657M 141.472M 147.936M
Total Stockholder Equity 125.318M 160.736M 169.249M 178.199M 158.489M
Other Current Liab 6.015M 5.75M 11.277M 27.63M 20.863M
Common Stock 265.206M 265.917M 257.411M 248.687M 210.36M
Capital Stock 265.206M 265.917M 257.411M 248.687M 210.36M
Retained Earnings -148.449M -119.857M -101.575M -81.468M -57.389M
Good Will - - - - -
Other Assets 1.133M 1.404M 3.207M 3.245M 3.291M
Cash 20.723M 21.179M 20.612M 47.078M 10.93M
Cash And Equivalents 20.723M 21.179M 20.612M 47.078M 10.93M
Total Current Liabilities 31.19M 27.672M 35.642M 47.139M 38.268M
Current Deferred Revenue - - 5.061M 5.818M -
Net Debt 76.622M 76.387M 86.511M 46.032M 85.777M
Short Term Debt 13.584M 12.606M 10.142M 6.043M 5M
Short Long Term Debt 13.056M 12M 9.75M 5.625M 5M
Short Long Term Debt Total 97.345M 97.566M 107.123M 93.11M 96.707M
Other Stockholder Equity 13.821M 11.717M 11.393M 11.517M 12.973M
Property Plant Equipment 1.127M 1.569M 1.384M 1.276M 0.363M
Total Current Assets 44.374M 43.751M 45.911M 63.1M 31.618M
Long Term Investments - - - - -
Short Term Investments - - - - -
Net Receivables 11.194M 11.511M 12.497M 11.858M 17.509M
Long Term Debt 83.279M 84.134M 96.205M 86.582M 91.707M
Inventory 8.902M 8.925M 10.63M 2.055M 1.505M
Accounts Payable 11.591M 9.316M 14.223M 13.466M 12.405M
Accumulated Other Comprehensive Income -5.26M 2.959M 2.02M -0.537M -7.455M
Non Currrent Assets Other 0.668M 0.714M 2.034M 2.188M 2.29M
Non Current Assets Total 197.278M 232.154M 257.995M 256.571M 274.807M
Capital Lease Obligations 1.01M 1.432M 1.168M 0.903M -
Long Term Debt Total 83.761M 84.96M 96.981M 87.067M 91.707M

Cash Flow

(Currency in CAD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019 31-12-2018
Investments -10.148M -4.51M -44.677M -15.359M -14.581M
Total Cashflows From Investing Activities -10.148M -4.51M -44.677M -15.359M -14.581M
Total Cash From Financing Activities -6.856M -11.398M 9.564M 23.947M -42.856M
Net Income -23.598M -13.117M -15.331M -19.552M -24.806M
Change In Cash -0.456M 0.567M -26.466M 36.148M -25.289M
Begin Period Cash Flow 21.179M 20.612M 47.078M 10.93M 36.219M
End Period Cash Flow 20.723M 21.179M 20.612M 47.078M 10.93M
Total Cash From Operating Activities 16.942M 16.429M 9.344M 26.408M 32.747M
Depreciation 34.402M 30.264M 33.186M 32.51M 32.395M
Other Cashflows From Investing Activities -10M -3.82M -12.05M -12.8M -13.8M
Dividends Paid 4.962M 5.122M 4.749M 4.332M 1.047M
Change To Inventory -0.622M 1.768M -8.077M -0.501M -0.236M
Sale Purchase Of Stock -0.998M -0.047M 1.635M 0.051M -0.924M
Other Cashflows From Financing Activities 9.545M 4.908M 20.977M -3.597M 92.166M
Capital Expenditures 10.148M 4.51M 44.677M 2.559M 0.781M
Change In Working Capital 1.547M -3.021M -7.665M 1.549M 6.455M
Other Non Cash Items 1.531M -1.187M -0.894M 10.381M 23.506M
Free Cash Flow 6.794M 11.919M -35.333M 23.849M 31.966M

No data found

Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Open in the App